Showing results (141-150 of 182) with videos related to

Sort By:
Pageof 19
Endocrine-Related Cancer|January 14, 2018
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trialMarianne Pavel, David J Gross, Marta Benavent, et al.
Neuroendocrinology|September 25, 2018
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) NeoplasmsEric Baudin, Aimee R Hayes, Jean-Yves Scoazec, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meetingMatthew H Kulke, Lillian L Siu, Joel E Tepper, et al.
Clinical Therapeutics|May 5, 2018
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid SyndromeMartin O Weickert, Gregory Kaltsas, Dieter Hörsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid SyndromeMatthew H Kulke, Dieter Hörsch, Martyn E Caplin, et al.
Clinical and Translational Gastroenterology|April 26, 2018
Plasma inflammatory cytokines and survival of pancreatic cancer patientsA Babic, N Schnure, N P Neupane, et al.
Pageof 19